Solid tumor Clinical Trials in Duarte, CA
As of August 2026, 45 paid clinical trials are recruiting for Solid tumor in Duarte, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Duarte
Filter results
Newly added in Duarte
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors
47 clinical trials for Solid tumor
·Clear filters·A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A Study of ASP3082 in Adults With Advanced Solid Tumors
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
A Study of BG-C477 in Participants With Advanced Solid Tumors
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
A Study of KK2269 in Adult Participants With Solid Tumors
This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors
A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors
Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Project: Every Child for Younger Patients With Cancer
Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors
L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance
Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer Survivors
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial
Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Top Research Study Locations in Duarte
Researchers run research studies in Duarte, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| City of Hope Medical Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Myelodysplastic Syndrome | 178 |
| City of Hope | Breast Cancer, Gastric Cancer, Cervical Cancer | 133 |
| City of Hope Comprehensive Cancer Center | Metastatic Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Hematopoietic and Lymphatic System Neoplasm | 84 |
| City of Hope National Medical Center | Breast Cancer, Solid Tumor, Advanced Solid Tumor | 53 |
| City of Hope (City of Hope National Medical Center, City of Hope Medical Center) | Pancreatic Ductal Adenocarcinoma, Acute Myeloid Leukemia, Advanced Breast Cancer | 9 |
| City of Hope Cancer Center | Advanced Solid Tumors, Breast Cancer, Cervical Cancer | 6 |
| City of Hope - Duarte Cancer Center | Advanced Metastatic Castration-resistant Prostate Cancer, Advanced Solid Tumors, Advanced/Metastatic Colorectal Adenocarcinoma | 5 |
| City of Hope - Duarte | Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations, Anemia, KRAS G12C-mutated Solid Tumors, Lung Cancer | 4 |
| City of Hope Duarte | Multiple Myeloma, Advanced Colorectal Cancer, CRC | 3 |
| City of Hope Cancer Center (Data collection only) | Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 3 |
| Beckman Research Institute of City of Hope | Cancer, End of Life, Prostate Cancer | 2 |
| City of Hope Investigational Drug Services (IDS) | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Advanced/Metastatic Urothelial Cancer | 2 |
| City of Hope National Cancer Center | Esophageal Cancer, Gastric Cancer (GC), Gastroesophageal Junction | 2 |
| Dren Investigational Site | Aggressive NK Cell Leukemia, Aplastic Anemias, Bone Marrow Failure Syndromes | 2 |
| IP Address: City of Hope Investigational Drug Services(IDS) | Acute Myeloid Leukemia, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms | 2 |
| Ascentage Investigative | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL | 1 |
| Beckman Research Institute of the City of Hope | Prostate Adenocarcinoma | 1 |
| City Of Hope Comprehensive Cancer Center | Advanced Squamous Tumors | 1 |
| City of Hope - Comprehensive Cancer Center (CCC) | Anemia, Myelodysplastic Syndrome | 1 |
| City of Hope - Duarte Main Site | Mild Thrombocytopenia, Moderate Thrombocytopenia, Myelofibrosis | 1 |
| City of Hope - National Medical Center | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 1 |
| City of Hope -Duarte Cancer Center | Ductal Carcinoma in Situ | 1 |
| City of Hope Blood Donor Center | Anemia, Anemia, Iron Deficiency, IDA - Iron Deficiency Anemia | 1 |
| City of Hope Cancer Center (Data Analysis Only) | Cancer, Recurrence, Recurrent | 1 |
| City of Hope Cancer Center (Data collection AND Specimen Analysis) | Acute Lymphoblastic Leukemia | 1 |
Active & Upcoming Studies in Duarte (2026)
Recruiting trials in Duarte grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (406 active studies)
- Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial · Phase 2 · City of Hope Medical Center
- Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma · Phase 1 · City of Hope Medical Center
Diabetes & metabolic (6 active studies)
- Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes · EARLY_Phase 1 · City of Hope Medical Center
- A Study of GNTI-122 in Adults Recently Diagnosed With T1D · Phase 1 · GentiBio, Inc
Vaccines (3 active studies)
- Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals · Phase 2 · Fred Hutchinson Cancer Center
- Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study · Phase 3 · Ansun Biopharma, Inc.
HIV / STI (2 active studies)
- Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma · Phase 1 · AIDS Malignancy Consortium
- CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS · EARLY_Phase 1 · City of Hope Medical Center
Neurology & pain (1 active study)
- Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma · University of Southern California
Cardiovascular (1 active study)
Common conditions studied in Duarte
- Acute Myeloid Leukemia (23 active studies)
- Breast Cancer (15 active studies)
- Multiple Myeloma (15 active studies)
- Myelodysplastic Syndrome (14 active studies)
- Ovarian Cancer (14 active studies)
- Malignant Solid Neoplasm (13 active studies)
Leading research sponsors in Duarte
- City of Hope Medical Center
- National Cancer Institute (NCI)
- AstraZeneca
- AbbVie
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Duarte?
There are approximately 548 recruiting clinical trials in Duarte, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Duarte pay participants?
Most recruiting trials in Duarte compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Duarte?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Duarte?
The most common conditions under active study in Duarte include Acute Myeloid Leukemia (23), Breast Cancer (15), Multiple Myeloma (15), Myelodysplastic Syndrome (14), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Duarte?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Duarte on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Duarte?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Duarte?
Recruiting research sites in Duarte include City of Hope Medical Center, City of Hope, City of Hope Comprehensive Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Duarte right now?
The largest active categories in Duarte are Cancer & tumors (406), Diabetes & metabolic (6), Vaccines (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.